UK short news takes: Tunstall names new chair, Alcidion patient safety software partners with East Lancashire NHS Trust

Tunstall Healthcare named Peter Nicklin as Chairman of the Board. Mr. Nicklin has had a varied career in healthcare, including stints at companies such as Baxter International, Bayer Healthcare, Novartis, and Bristol-Myers Squibb. Before joining Tunstall, he was Chairman of Versantis, a Swiss pharmaceutical company, as well as Chairman of the Board of Healthcare at Home a leading pharma services company, focused on chronic, rare disease and oncology medicine management services. Prior to that, he was CEO and board member of Amann Girrbach AG of Koblach, Austria. Mr. Nicklin and his impressive background arrives at an interesting time for Tunstall, some months past a reorganization, purchase by a Jersey-based group [TTA 30 Oct 20], and a blistering market for health tech and associated in the US which hasn’t quite spread to the UK. Tunstall release 

Alcidion‘s Patientrack, a patient status monitoring software used to track patient conditions, particularly safety and deteriorating vital signs needing immediate attention, at bedside and remotely, announced a five-year, five hospital deal with East Lancashire Hospitals NHS Trust. Patientrack will integrate with East Lancashire’s Cerner Millenium EHR. Alcidion markets in the UK, Australia, and New Zealand, and was founded and remains HQ’d in Australia in 2000. Unusually for software, the chair and the group managing director are women.  Release

Categories: Latest News.